Immigration and access to dementia diagnostics and treatment: A nationwide study in Sweden

• Published in: SSM - population health Vol. 25; p. 101573
• Main Authors: Hoang, Minh Tuan, Kåreholt, Ingemar, Lindgren, Emma, von Koch, Lena, Xu, Hong, Tan, Edwin C.K., Johnell, Kristina, Nägga, Katarina, Eriksdotter, Maria, Garcia-Ptacek, Sara
• Format: Journal Article
• Language: English
• Published: England Elsevier Ltd 01.03.2024; Elsevier
• Subjects: adult; aged; angiotensin receptor antagonist; antidepressant agent; anxiolytic agent; beta adrenergic receptor blocking agent; calcium channel blocking agent; cholinesterase inhibitor; clinical feature; cohort analysis; comparative study; controlled study; Dementia; Diagnosis; Difference; dipeptidyl carboxypeptidase inhibitor; diuretic agent; Drug; Ethnic; ethnicity; female; Folkhälsovetenskap, global hälsa, socialmedicin och epidemiologi; Geriatrik; health care access; health disparity; Health Sciences; human; hydroxymethylglutaryl coenzyme A reductase inhibitor; hypnotic agent; Hälsovetenskap; immigration; Inequality; Klinisk medicin; major clinical study; male; Medical and Health Sciences; Medicin och hälsovetenskap; memantine; middle aged; neuroleptic agent; Neurologi; observational study; prescription; Public Health, Global Health, Social Medicine and Epidemiology; sensitivity analysis; Sweden; Treatment; very elderly; Drug; Treatment; Diagnosis; Difference; Ethnic; Dementia; Inequality
• ISSN: 2352-8273; 2352-8273
• DOI: 10.1016/j.ssmph.2023.101573

•Compared to Swedish-born people, foreign-born people were less likely to receive dementia diagnostic tests.•Being born in Africa or Europe was associated with lower chance of receiving cholinesterase inhibitors.•Asian-born people had higher chance of receiving cholinesterase inhibitors, but were less likely to receive memantine.•Disparities existed in dementia diagnostics and treatment between Swedish-born and foreign-born people, but were not consistent after adjusting for MMSE scores.